1Department of Coronary and Structural Heart Diseases, Institute of Cardiology, Warsaw, Poland
2Department of Epidemiology, Cardiovascular Disease Prevention and Health Promotion, Institute of Cardiology, Warsaw, Poland
3Department of Interventional Cardiology and Angiology, Institute of Cardiology, Warsaw, Poland.
Address correspondence to: Karolina Ewa Kryczka, MD, PhD, Department of Coronary and Structural Heart Diseases, Institute of Cardiology, Alpejska 42, 04-628 Warszawa, Poland. E-mail: [email protected], [email protected]
Received 5 July, 2017
Revised 16 October, 2017
Accepted 16 October, 2017
Funding/support: This study was supported by a grant from the Polish Ministry of Science and Higher Education (Grant no. 2 P05B 013 28) and by a grant from Warsaw University of Medicine (Grant no. 1 WY/W1/10).
Financial disclosure/conflicts of interest: Dr Kryczka receives grant funding for the International Study of Comparative Health Effectiveness With Medical and Invasive Approaches trial from the National Institutes of Health and National Heart, Lung, and Blood Institute. She also receives grant funding from the effect of Ticagrelor on Health outcomes in diabEtes Mellitus patients Intervention Study trial and AstraZeneca. She received grant funding from Boehringer Ingelheim International.